Literature DB >> 34768027

Innate immune defenses at the maternal-fetal interface.

Eleanor C Semmes1, Carolyn B Coyne2.   

Abstract

The human maternal-fetal interface is an immunologically complex environment that must balance the divergent demands of tolerance towards the developing fetus with anti-pathogen defense. The innate immune responses at the maternal-fetal interface that function in anti-microbial defense have been understudied to-date and how 'TORCH' pathogens evade maternal innate immunity to infect the fetus remains poorly understood. Herein, we discuss how newly described decidual innate lymphoid cells and maternal placenta-associated macrophage subsets may be involved in anti-pathogen defense. Moreover, we outline recent advances in our understanding of how placental trophoblasts and fetal-derived macrophages (Hofbauer cells) function in anti-microbial defense. In summary, we highlight current gaps in knowledge and describe novel experimental models of the human decidua and placenta that are poised to advance our knowledge of innate immune defenses at the maternal-fetal interface.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34768027     DOI: 10.1016/j.coi.2021.10.007

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  3 in total

Review 1.  Fetal inflammatory response at the fetomaternal interface: A requirement for labor at term and preterm.

Authors:  Ramkumar Menon
Journal:  Immunol Rev       Date:  2022-03-14       Impact factor: 10.983

2.  Innate immune signaling in trophoblast and decidua organoids defines differential antiviral defenses at the maternal-fetal interface.

Authors:  Liheng Yang; Eleanor C Semmes; Cristian Ovies; Christina Megli; Sallie Permar; Jennifer B Gilner; Carolyn B Coyne
Journal:  Elife       Date:  2022-08-17       Impact factor: 8.713

3.  Maternal Fc-mediated non-neutralizing antibody responses correlate with protection against congenital human cytomegalovirus infection.

Authors:  Eleanor C Semmes; Itzayana G Miller; Courtney E Wimberly; Caroline T Phan; Jennifer A Jenks; Melissa J Harnois; Stella J Berendam; Helen Webster; Jillian H Hurst; Joanne Kurtzberg; Genevieve G Fouda; Kyle M Walsh; Sallie R Permar
Journal:  J Clin Invest       Date:  2022-08-15       Impact factor: 19.456

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.